News
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana. Roche, a Swiss company, ...
2h
Dealbreaker on MSNRoche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs LoomRoche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, ...
The Landmarks Preservation Commission on Tuesday voted to approve architect Frida Escobedo's design for a new wing at The Met ...
The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...
Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new ...
Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...
Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...
NEW YORK – Roche announced on Wednesday that it has received CE marking for its Chest Pain Triage algorithm to help rule in and rule out heart attacks in the emergency department.
Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...
Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...
Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results